絞り込み

16314

広告

アジア各地に邦楽の公演可能なライブホール開設を発表

大手音楽会社のソニー・ミュージックエンタテインメントとそのグループ会社は、官民ファンドの支援を受けて、アジア各地に日本のアーティストなどが公演を行えるライブホー...

  1. ヒートショックプロテインを増やす入浴法 ...
  2. 痛風対策してますか?食事・運動・サプリメ...
  3. 英エコノミスト誌が予測「日本は人口減少で...
  4. 高浜原発4号機 燃料入れる作業始まる 来...

ニュース一覧

「vonoprazan」の検索結果

74件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia.

Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial.

Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.

Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy.

Effect of Therapeutic and Supratherapeutic Doses of Vonoprazan on the QT/QTc Interval in a Phase I Randomized Study in Healthy Subjects.

Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis.

Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.

Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the (13)C-Urea Breath Test in Helicobacter pylori-Positive Patients.

A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.

Successful Eradication Therapy for Helicobacter pylori-positive Atrophic Gastritis at the Sixth Attempt: A Case Report.

Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study.

Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers.

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials.

Helicobacter pylori-related diseases.

Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori.

Effects of vonoprazan on intractable NSAID-induced ulcers that cannot be controlled with conventional proton pump inhibitors: a case report.

Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.

Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence.

  1. 1
  2. 2
  3. 3
  4. 4
Sort by
※並べ替えは表示に時間がかかります